IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

Puja Kachroo(USC Norris Comprehensive Cancer Center), Jay M. Lee(University of California, Los Angeles)

Journal of Experimental & Clinical Cancer Research

November 25, 2013

10.1186/1756-9966-32-97

Cited by 80

Related Papers

Phase I trial of <i>in situ</i> vaccination with autologous <i>CCL21</i>-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC.

|Journal of Clinical Oncology|2021|2

Abstract CT153: Phase I trial of intratumoral administration of autologous <i>CCL21</i> gene-modified dendritic cells in combination with pembrolizumab for advanced NSCLC: Feasibility of repeated IT injections

|Cancer Research|2024|1